In our study, silencing of COL6 in GBM cells induced the downregulation of genes associated with cancer-relevant pathways, including PI3K/AKT, IGF1, FLT3, PDGF, and MAPK pathways. The gene discussed is AKT1; the disease is glioblastoma.